Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)

Conditions:   Chronic Idiopathic Urticaria;   AtopyInterventions:   Drug: desloratadine;   Drug: PlaceboSponsor:   Merck Sharp & Dohme Corp.Completed - verified April 2015

Source: ClinicalTrials.gov - September 22, 2008 Category: Research Source Type: clinical trials